Iodine-131 metaiodobenzylguanidine (I-31 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma: Current problems, critical issues and presentation of a sample case

M. R. Castellani; C. Aktolun; R. Buzzoni; E. Seregni; C. Chiesa; M. Maccauro; G. L. Aliberti; C. Vellani; A. Lorenzoni; E. Bombardieri

Iodine-131 metaiodobenzylguanidine (I-31 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma: Current problems, critical issues and presentation of a sample case

M. R. Castellani, C. Aktolun, R. Buzzoni, E. Seregni, C. Chiesa, M. Maccauro, G. L. Aliberti, C. Vellani, A. Lorenzoni, E. Bombardieri

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Article › peer-review

Abstract

Iodine-131 metaiodobenzylguanidine (I-131 MIBG) has been used for the diagnosis and treatment of malignant pheochromocytomas (PHEO) and paragangliomas (PGL) since 1980's. Despite increasing amount of experience with iodine-131 (I-131) MIBG therapy, many important questions still exist. In this article, we will discuss the current problems learned from clinical experience in diagnosis and therapy of PHEO/PGL with I-131 MIBG, and present a sample case to emphasize the critical aspects for an optimal treatment strategy.

Original language	English
Pages (from-to)	146-152
Number of pages	7
Journal	Quarterly Journal of Nuclear Medicine and Molecular Imaging
Volume	57
Issue number	2
Publication status	Published - Jun 2013

Keywords

Adrenal glands
Neural crest tumor
Neuroendocrine tumors
Positron emission tomography

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Iodine-131 metaiodobenzylguanidine (I-31 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma: Current problems, critical issues and presentation of a sample case'. Together they form a unique fingerprint.

Cite this

Castellani, M. R., Aktolun, C., Buzzoni, R., Seregni, E., Chiesa, C., Maccauro, M., Aliberti, G. L., Vellani, C., Lorenzoni, A., & Bombardieri, E. (2013). Iodine-131 metaiodobenzylguanidine (I-31 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma: Current problems, critical issues and presentation of a sample case. Quarterly Journal of Nuclear Medicine and Molecular Imaging, 57(2), 146-152.

Iodine-131 metaiodobenzylguanidine (I-31 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma : Current problems, critical issues and presentation of a sample case. / Castellani, M. R.; Aktolun, C.; Buzzoni, R.; Seregni, E.; Chiesa, C.; Maccauro, M.; Aliberti, G. L.; Vellani, C.; Lorenzoni, A.; Bombardieri, E.

In: Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 57, No. 2, 06.2013, p. 146-152.

Research output: Contribution to journal › Article › peer-review

Castellani, MR, Aktolun, C, Buzzoni, R, Seregni, E , Chiesa, C , Maccauro, M, Aliberti, GL, Vellani, C, Lorenzoni, A & Bombardieri, E 2013, 'Iodine-131 metaiodobenzylguanidine (I-31 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma: Current problems, critical issues and presentation of a sample case', Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol. 57, no. 2, pp. 146-152.

Castellani, M. R. ; Aktolun, C. ; Buzzoni, R. ; Seregni, E. ; Chiesa, C. ; Maccauro, M. ; Aliberti, G. L. ; Vellani, C. ; Lorenzoni, A. ; Bombardieri, E. / Iodine-131 metaiodobenzylguanidine (I-31 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma : Current problems, critical issues and presentation of a sample case. In: Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2013 ; Vol. 57, No. 2. pp. 146-152.

@article{29ba3ad8a5cc40bbb0a4bea381d8b911,

title = "Iodine-131 metaiodobenzylguanidine (I-31 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma: Current problems, critical issues and presentation of a sample case",

abstract = "Iodine-131 metaiodobenzylguanidine (I-131 MIBG) has been used for the diagnosis and treatment of malignant pheochromocytomas (PHEO) and paragangliomas (PGL) since 1980's. Despite increasing amount of experience with iodine-131 (I-131) MIBG therapy, many important questions still exist. In this article, we will discuss the current problems learned from clinical experience in diagnosis and therapy of PHEO/PGL with I-131 MIBG, and present a sample case to emphasize the critical aspects for an optimal treatment strategy.",

keywords = "Adrenal glands, Neural crest tumor, Neuroendocrine tumors, Positron emission tomography",

author = "Castellani, {M. R.} and C. Aktolun and R. Buzzoni and E. Seregni and C. Chiesa and M. Maccauro and Aliberti, {G. L.} and C. Vellani and A. Lorenzoni and E. Bombardieri",

year = "2013",

month = jun,

language = "English",

volume = "57",

pages = "146--152",

journal = "Quarterly Journal of Nuclear Medicine and Molecular Imaging",

issn = "1824-4785",

publisher = "Edizioni Minerva Medica S.p.A.",

number = "2",

}

TY - JOUR

T1 - Iodine-131 metaiodobenzylguanidine (I-31 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma

T2 - Current problems, critical issues and presentation of a sample case

AU - Castellani, M. R.

AU - Aktolun, C.

AU - Buzzoni, R.

AU - Seregni, E.

AU - Chiesa, C.

AU - Maccauro, M.

AU - Aliberti, G. L.

AU - Vellani, C.

AU - Lorenzoni, A.

AU - Bombardieri, E.

PY - 2013/6

Y1 - 2013/6

N2 - Iodine-131 metaiodobenzylguanidine (I-131 MIBG) has been used for the diagnosis and treatment of malignant pheochromocytomas (PHEO) and paragangliomas (PGL) since 1980's. Despite increasing amount of experience with iodine-131 (I-131) MIBG therapy, many important questions still exist. In this article, we will discuss the current problems learned from clinical experience in diagnosis and therapy of PHEO/PGL with I-131 MIBG, and present a sample case to emphasize the critical aspects for an optimal treatment strategy.

AB - Iodine-131 metaiodobenzylguanidine (I-131 MIBG) has been used for the diagnosis and treatment of malignant pheochromocytomas (PHEO) and paragangliomas (PGL) since 1980's. Despite increasing amount of experience with iodine-131 (I-131) MIBG therapy, many important questions still exist. In this article, we will discuss the current problems learned from clinical experience in diagnosis and therapy of PHEO/PGL with I-131 MIBG, and present a sample case to emphasize the critical aspects for an optimal treatment strategy.

KW - Adrenal glands

KW - Neural crest tumor

KW - Neuroendocrine tumors

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=84882443965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882443965&partnerID=8YFLogxK

M3 - Article

C2 - 23822990

AN - SCOPUS:84882443965

VL - 57

SP - 146

EP - 152

JO - Quarterly Journal of Nuclear Medicine and Molecular Imaging

JF - Quarterly Journal of Nuclear Medicine and Molecular Imaging

SN - 1824-4785

IS - 2

ER -

Iodine-131 metaiodobenzylguanidine (I-31 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma: Current problems, critical issues and presentation of a sample case

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Cite this